Tarr Mark J 4
4 · Encompass Health Corp · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Encompass Health (EHC) CEO Mark J. Tarr Sells 150,000 Shares
What Happened
Mark J. Tarr, President & CEO and a director of Encompass Health Corporation (EHC), sold a total of 150,000 common shares in open-market transactions on February 11, 2026. The trades were reported on an SEC Form 4 filed February 12, 2026. The sales were executed in multiple lots at weighted-average prices and individual prices ranging roughly from $107.47 up to $113.58, generating aggregate proceeds of approximately $16,746,689.
Key Details
- Transaction date: February 11, 2026; Form 4 filed February 12, 2026 (timely filing).
- Individual lots reported:
- 16,216 shares at $108.03 (F1; weighted avg; prices in range $107.47–$108.45) — $1,751,814
- 13,231 shares at $108.80 (F2; weighted avg; $108.47–$109.17) — $1,439,533
- 15,584 shares at $110.07 (F3; weighted avg; $109.52–$110.51) — $1,715,331
- 10,954 shares at $110.92 (F4; weighted avg; $110.52–$111.51) — $1,215,018
- 6,057 shares at $111.89 (F5; weighted avg; $111.55–$112.53) — $677,718
- 87,745 shares at $113.09 (F6; weighted avg; $112.58–$113.52) — $9,923,082
- 213 shares at $113.58 (single-price lot) — $24,193
- Total: 150,000 shares sold for about $16,746,689.
- Footnotes F1–F6 indicate the reported per-share prices are weighted averages across multiple trades; the filing says full per-price breakdowns will be provided upon request.
- Shares owned after the transactions are not included in the details you provided — see the full Form 4 filing for post-transaction holdings.
- No indication in the provided data of a 10b5-1 plan, gift, option exercise, or tax-withholding disposition; this was an open-market sale.
Context
These were sales (disposals), which are common for executives for reasons such as diversification, tax planning, or liquidity needs; sales do not necessarily indicate negative views about the company. Purchases typically carry more direct bullish signal than routine sales. Retail investors who want the exact post-transaction holdings or the per-trade price breakdowns should review the full SEC Form 4 (accession 0000785161-26-000032) or request the detailed breakdown referenced in the footnotes.
Insider Transaction Report
- Sale
Encompass Health Common Stock
[F1]2026-02-11$108.03/sh−16,216$1,751,814→ 510,854 total - Sale
Encompass Health Common Stock
[F2]2026-02-11$108.80/sh−13,231$1,439,533→ 497,623 total - Sale
Encompass Health Common Stock
[F3]2026-02-11$110.07/sh−15,584$1,715,331→ 482,039 total - Sale
Encompass Health Common Stock
[F4]2026-02-11$110.92/sh−10,954$1,215,018→ 471,085 total - Sale
Encompass Health Common Stock
[F5]2026-02-11$111.89/sh−6,057$677,718→ 465,028 total - Sale
Encompass Health Common Stock
[F6]2026-02-11$113.09/sh−87,745$9,923,082→ 377,283 total - Sale
Encompass Health Common Stock
2026-02-11$113.58/sh−213$24,193→ 377,070 total
Footnotes (6)
- [F1]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $108.45, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F2]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.17, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F3]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.52 to $110.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F4]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.52 to $111.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F5]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.55 to $112.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F6]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.58 to $113.52, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.